Cantor Fitzgerald maintains Vertex stock at Overweight, $480 target
Cantor Fitzgerald reiterated its Overweight rating and a $480.00 price target for Vertex Pharmaceuticals Incorporated (NASDAQ ...
Cantor Fitzgerald Reaffirms Their Buy Rating on Cigna (CI)
Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...
Hosted on MSN19h
Cantor Fitzgerald Upgrades Lam Research (LRCX)
Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (NasdaqGS:LRCX) from ...
Cantor Fitzgerald Suit Against Ex-Bankers’ Firm Is Dismissed
Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.
Lam upgraded to Overweight at Cantor Fitzgerald, says ‘too good to wait’
Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...
Rochester Sentinel2d
Trump commerce pick says favors broad tariffs, vows tough China stance
Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" ...
Vincennes Sun-Commercial2d
US commerce secretary pick favors sweeping tariffs, hawkish China stance
Donald Trump's commerce secretary nominee said Wednesday that he favors "across-the-board" tariffs and a country-based ...